Posted by Michael Wonder on 19 Apr 2022
iHealthScreen announces TGA approval for iPredict automated AI system for early diagnosis of diabetic retinopathy, age-related macular degeneration and glaucoma suspect
19 April 2022 - iHealthScreen is the first company in the USA to receive a CE certification, Australian Health approval, and Abu Dhabi Health approval for simultaneous diagnosis of diabetic retinopathy, age-related macular degeneration and glaucoma suspects.
iPredict AI Eye Screening System provides fully automated diabetic retinopathy, age-related macular degeneration and glaucoma suspect screening, including retinal imaging, and immediate reporting of actionable results.
